Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
246.41M | 228.26M | 217.77M | 187.51M | 190.19M | 175.69M | Gross Profit |
233.14M | 214.71M | 208.18M | 178.13M | 186.62M | 170.98M | EBIT |
135.91M | 124.06M | 186.37M | 112.44M | 106.56M | 104.56M | EBITDA |
250.82M | 211.54M | 145.80M | 162.81M | 161.96M | 157.38M | Net Income Common Stockholders |
162.14M | 125.08M | 53.73M | 42.87M | 48.30M | 57.21M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
26.51M | 213.82M | 294.45M | 13.18M | 19.89M | 18.92M | Total Assets |
3.88B | 3.44B | 2.08B | 1.62B | 1.64B | 1.50B | Total Debt |
822.15M | 396.93M | 595.60M | 719.50M | 673.40M | 545.59M | Net Debt |
795.64M | 183.10M | 301.15M | 706.32M | 653.50M | 526.67M | Total Liabilities |
936.27M | 507.63M | 666.12M | 771.41M | 725.09M | 589.42M | Stockholders Equity |
2.93B | 2.91B | 1.42B | 849.37M | 915.76M | 914.14M |
Cash Flow | Free Cash Flow | ||||
256.88M | 236.20M | 143.79M | 137.12M | 150.86M | 137.44M | Operating Cash Flow |
266.81M | 244.25M | 154.77M | 144.41M | 156.87M | 145.74M | Investing Cash Flow |
-1.43B | -1.51B | -267.81M | -127.40M | -192.63M | -41.58M | Financing Cash Flow |
1.34B | 1.19B | 394.32M | -23.73M | 36.74M | -105.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $5.52B | 31.39 | 7.02% | 4.65% | 43.27% | 80.97% | |
77 Outperform | $4.33B | 30.82 | 5.15% | 6.59% | 7.81% | 179.16% | |
72 Outperform | $3.31B | 22.51 | 10.56% | 5.08% | 7.44% | 4.23% | |
64 Neutral | $5.72B | ― | -1.93% | 2.82% | 11.30% | ― | |
61 Neutral | $2.83B | 10.72 | 0.40% | 6.10% | 5.80% | -21.26% | |
49 Neutral | $5.25B | ― | -6.83% | 8.30% | -7.26% | 18.45% | |
44 Neutral | $2.65B | ― | -28.86% | 7.26% | 19.56% | -12.73% |
On May 30, 2025, CareTrust REIT, Inc. entered into an amendment to its credit and guaranty agreement, introducing a $500 million unsecured term loan facility alongside its existing $1.2 billion revolving credit facility. This move is expected to help the company pay off existing debt, fund acquisitions, and support general corporate purposes, potentially enhancing its financial flexibility and positioning in the healthcare real estate market.
The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.
CareTrust REIT, Inc. has released an updated investor presentation available on their website. The company clarifies that this update is not mandated by securities laws and does not include undisclosed material investor information.
The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.
On May 8, 2025, CareTrust REIT, Inc. completed the acquisition of Care REIT plc through a court-sanctioned scheme of arrangement. The acquisition, valued at approximately $840.5 million, was funded through cash and borrowing under an existing credit facility, enhancing CareTrust’s portfolio in the healthcare real estate sector.
The most recent analyst rating on (CTRE) stock is a Buy with a $35.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.
CareTrust REIT reported its first quarter 2025 results, highlighting a net income of $65.8 million and a planned acquisition of Care REIT plc, which was approved by Care REIT’s shareholders. The acquisition is expected to enhance CareTrust’s portfolio diversification and growth potential. The company also increased its quarterly dividend and announced plans to upsize its credit facility, reflecting a strong financial position and commitment to shareholder returns.